French Govt Plans New Promo Move
New drug promotion legislation to force pharmaceutical companies to supply doctors with official assessment by government experts on their products has been drafted by the French government. The move is meant to dampen excessive drug promotion and comes 18 months after legislation banning gifts from companies to doctors.
A preliminary draft of the new regulations has been submitted to the State Council and is expected to become law by the end of the current year.
The government has been prompted to act by the need to transcribe a European Union directive of March 1992 into French law. EU member states were supposed to have adopted the directive by January 1993, and the French authorities are keen to remedy their delay before they assume the EU presidency next January.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze